Recent studies of long-term anabolic-androgenic steroid (AAS) users reported amygdala structural and functional connectivity abnormalities. We assessed white matter microstructure in the inferior-fronto-occipital fasciculus (IFOF), a major associative bundle of the amygdala network. Diffusion weighted images acquired from 9 male long-term AAS users and 8 matched controls aged 36-51 years old were processed using a standardized pipeline (Tract-Based Spatial Statistics). Group differences were examined using linear regression with adjustment for age and current testosterone level. Compared to nonusers, AAS users exhibited significantly higher fractional anisotropy (FA) in the IFOF. Users showed markedly greater FA than nonusers on the left IFOF but only a modest, nonsignificant difference on the right IFOF. Moreover, FA was positively associated with lifetime cumulative AAS dose. Our results suggest that long-term AAS use alters IFOF white matter organization and integrity, which in turn might affect amygdala-related processes such as reward system function. Accordingly, further studies are needed to replicate findings in larger subject groups to determine the functional significance of the FA abnormality.
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Introduction
The anabolic-androgenic steroids (AAS) are a group of hormones including testosterone and its synthetic derivatives such as nandrolone or stanozolol. These drugs are widely used by athlete and non-athlete weightlifters to improve performance or personal appearance (Pope et al., 2014a) . Prior to the 1980s, AAS use was confined largely to elite athletes. However, in the last several decades, AAS use has spread widely into the general population (Kanayama et al., 2008) . Today, there are nearly 4 million current or past users in the United States alone, virtually all male, of whom about 1 million have developed AAS dependence (Pope et al., 2014b) . Human and animal studies have reported adverse effects of AAS use on the cardiovascular system (Achar et al., 2010; Baggish et al., 2010; Vanberg and Atar, 2010) , the hypothalamic-pituitary-gonadal axis (Flanagan and Lehtihet, 2015; Kanayama et al., 2015b) , and several other organ systems, including the hepatic (Martin et al., 2008; Solbach et al., 2015 ), urogenital (Harrington et al., 2011 Herlitz et al., 2010) and musculoskeletal systems (Kanayama et al., 2015a) . It is also well recognized that AAS may cause acute psychiatric effects in some individuals, with hypomanic symptoms such as irritability, aggressiveness, and even violence during AAS exposure, and depressive symptoms during AAS withdrawal (Pope et al., 2014b) . These psychiatric effects have been reported in numerous field studies of AAS users (Pope et al., 2014b) , and have also been observed in blinded laboratory investigations administering supraphysiologic doses of AAS to normal volunteers (Pope et al., 2000; Su et al., 1993) .
In addition to their acute psychiatric effects, AAS may also induce chronic neurotoxic effects. This possibility has been suggested by several recent laboratory studies showing apoptotic or other neurotoxic effects in mammalian or human neuronal cells exposed to supraphysiologic levels of testosterone or other AAS, at levels comparable to 
